The Latin America, Middle East and Africa Vendor Neutral Archive (VNA) & PACS Market would witness market growth of 11.8% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Vendor Neutral Archive (VNA) & PACS Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $178.2 million by 2031. The Argentina market is showcasing a CAGR of 13% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 11.4% during (2024 - 2031).
Compliance with regulatory standards and quality improvement initiatives is a key driver for adopting VNA and PACS systems. Healthcare organizations are adopting these systems to ensure adherence to regulations such as HIPAA and DICOM, which mandate secure and standardized handling of imaging data. Additionally, VNA and PACS support quality improvement efforts by providing tools for monitoring and enhancing diagnostic accuracy and patient care.
The need for seamless data interoperability between different healthcare systems drives VNA and PACS solutions adoption. These systems enable the exchange and integration of imaging data across diverse platforms and healthcare networks, facilitating better coordination of care and improving patient outcomes by ensuring that all relevant data is accessible to healthcare providers.
The expansion of investment in addressing non-communicable diseases (NCDs) in Saudi Arabia is having a significant impact on the vendor neutral archive (VNA) and PACS market. With NCDs accounting for 68 percent of all deaths in the country, there is a critical need for advanced healthcare solutions that facilitate efficient data management and improved patient care. The rising healthcare budget in the UAE will lead to increased investment in advanced imaging infrastructure across hospitals and clinics. This will drive the adoption of cutting-edge PACS solutions to support managing and storing high-resolution imaging data. As per the International Trade Administration (ITA), in the UAE's 2022 federal budget, a total of USD 15.8 billion (AED 58.931 billion) was approved for public spending, of which 8.4% is dedicated to healthcare. In conclusion, the rising investment in non-communicable diseases in Saudi Arabia and rising healthcare budget in UAE is poised to propel the market.
Free Valuable Insights: The Worldwide Vendor Neutral Archive (VNA) & PACS Market is Projected to reach USD 8.3 Billion by 2031, at a CAGR of 9.3%
Based on Product Type, the market is segmented into VNA (Multi-Department VNA, Department VNA, and Multi-Site VNA) and PACS (Multi-Department PACS, Department PACS, and Multi-Site PACS). Based on Vendor Type, the market is segmented into Independent Vendor and Third-party Vendor. Based on Deployment, the market is segmented into On-Premise, Cloud-Based, and Hybrid Model. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others. Based on Application, the market is segmented into Cardiology, Orthopedic, Oncology, Neurology, Obstetrics & Gynecology, and Others. Based on Modality, the market is segmented into Computed Tomography, Mammography, MRI, Ultrasound, X-Rays, and PET. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
By Product Type
By Vendor Type
By Deployment
By End User
By Application
By Modality
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 